Monitor for the actual definitive proxy statement (DEF14A) and any related SC 13D filings to understand the specific activist demands and board proposals. The cross-filing amplifier signals suggest elevated probability of a contested proxy fight — watch for dissident nominee slate and management response.
Price Chart
Executive Summary
Syndax Pharmaceuticals filed a DEFA14A (additional definitive proxy soliciting materials) on April 30, 2026. The filing is a definitive additional proxy statement, but the actual document content is unavailable — only the SEC filing header and metadata are provided. The filing type suggests ongoing proxy solicitation activity, but without document text, no specific proposals, activist demands, or financial figures can be extracted.
Key Facts
- Filed DEFA14A on April 30, 2026
- Filed by Syndax Pharmaceuticals Inc (ticker: SNDX)
- Document content was not available for analysis
- Market cap: $1.8B with 95% analyst bullish consensus
- Cross-filing context indicates dissident proxy activity (activist context, DEF14A context, executive change context, preliminary context) — all flagged as amplifiers
Financial Impact
No financial figures available from filing documents
Risk Factors
- Potential activist campaign could lead to board changes or strategic review
- Uncertainty due to lack of document content
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-197877 |
| Document: 0001193125-26-197877-index-headers.html | 0001193125-26-197877 |
| Document: 0001193125-26-197877-index.html | 0001193125-26-197877 |
| Document: 0001193125-26-197877.txt | 0001193125-26-197877 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 14, 2026 11w ago | 8-K | $24.13 $20.29 | ▼ −15.91% | ▼ −18.41% | $17.60 (−27.06%) |
Jul 1, 2026 13w ago | Press Release | $21.82 $19.48 | ▼ −10.72% | ▼ −10.31% | $17.60 (−19.34%) |
Jun 11, 2026 16w ago | Press Release | $17.91 $24.84 | ▲ +38.69% | ▲ +36.80% | $17.60 (−1.73%) |
Jun 10, 2026 16w ago | 8-K | $17.91 $24.84 | ▲ +38.69% | ▲ +36.80% | $17.60 (−1.73%) |
Jun 4, 2026 17w ago | Press Release | $17.34 $22.08 | ▲ +27.34% | ▲ +25.47% | $17.60 (+1.50%) |
Jun 4, 2026 17w ago | DEFA14A | $18.02 $21.82 | ▲ +21.09% | ▲ +22.46% | $17.60 (−2.33%) |
Jun 4, 2026 17w ago | 8-K | $18.02 $21.82 | ▲ +21.09% | ▲ +22.46% | $17.60 (−2.33%) |
Apr 30, 2026 22w ago | DEFA14A | $19.11 $18.85 | ▼ −1.36% | ▼ −6.64% | $17.60 (−7.90%) |
Apr 24, 2026 23w ago | Press Release | $21.39 $19.77 | ▼ −7.57% | ▼ −11.60% | $17.60 (−17.72%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access